
Will AstraZeneca be the UK’s first £200bn company?
AstraZeneca, Pharmaceuticals industry, Business Business | The Guardian The former pharma laggard is in a race with Shell to be the first FTSE 100 stock to be valued at £200bnThe last time the AstraZeneca chief executive, Pascal Soriot, set long-term sales targets, he was greeted with a chorus of scepticism. It was 2014 and the company…